Table 2

Definitions of remission of polymyalgia rheumatica from the published literature

ReferenceHistoryClinical examinationESR (mm/1st h)CRP (mg/dl)Blood countFibrinogen (μmol/l)Therapy
Behn et al30ACS<30
Cantini et al27ACS<40<0.5*
Catanoso et al9Absence of systemic symptoms (fever, malaise, anorexia, weight loss), MS, girdles and neck pain and peripheral synovitis<40<0.5*
Chuang et al41ACSNormal laboratory findings
Dasgupta et al42≥50% pain reduction (VAS) MS <30 min<20Hb >12 g/dl
Delecoeuillerie et al43ACS
Feinberg et al44Absence of pain on examinationNV
Ferraccioli et al45Absence of myalgiasNVNV
Hutchings et al46≥50% improvement in shoulder and pelvic girdle pain on a VAS, MS ≤30 min≤30≤1.0
Kremers et al31 34 35ACSNVCS ≤5 mg/day
Krogsgaard et al47No muscular pain, no MSNo muscular tendernessNVNVLowest CS possible
Martinez-Taboada et al48ACSNV
Mertens et al49ACS
Proven et al36ACS
Salvarani et al26ACS≤30≤0.5*
Salvarani et al8ACSNV
Van der Veen et al50Discontinuation of prednisone and trial medication
  • * The upper limit of normal is 0.5 mg/dl; for the other studies, no upper limit of normal CRP levels was reported.

  • –, parameter not mentioned in the definition.

  • ACS, absence of clinical symptoms (not further specified); CRP, C-reactive protein; CS, corticosteroid dose; ESR, erythrocyte sedimentation rate; Hb, haemoglobin; MS, morning stiffness; NV, normal values; VAS, measured on a visual analogue scale ranging from 0 (best) to 10 (worst) cm.